World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0006657979
Reproduction Date:

Title: Norethisterone  
Author: World Heritage Encyclopedia
Language: English
Subject: Cyproterone acetate, Quingestanol acetate, Delmadinone acetate, Cyanoketone, Metyrapone
Collection: Androgens, Progestogens, Steroids, Syntex
Publisher: World Heritage Encyclopedia


Systematic (IUPAC) name
Clinical data
Pharmacokinetic data
Bioavailability 64%
Protein binding >95%
Biological half-life 7 hours
CAS Registry Number  Y
ATC code G03 G03
PubChem CID:
DrugBank  Y
ChemSpider  Y
Chemical data
Formula C20H26O2
Molecular mass 298.419 g/mol

Norethisterone, also known as norethindrone, as well as 19-nor-17α-ethynyltestosterone, but more commonly known under its trade name Utovlan® is a Syntex in Mexico City in 1951.[1] It was the progestin used in one of the first three oral contraceptives. Its related ester, norethisterone acetate, is used for the same indications.


  • Synthesis 1
  • Ethynerone 2
  • See also 3
  • References 4


Norethisterone synthesis:[2][1]

Estradiol methyl ether (1, EME) is partially reduced to the 1,5-diene (2) as also occurs for the first step in the synthesis of nandrolone. Oppenauer oxidation then transforms the 17β alcohol into a ketone functionality (3). This is then reacted with metal acetylide into the corresponding 17α-ethynyl compound (4). Hydrolysis of the enolether under mild conditions leads directly to (5),[2] which appears to be Norethynodrel (although Lednicer states that it is Ethynodrel in his book. This search term was corrected to Etynodiol in chemspider. Ethynodrel is with a chlorine atom attached.) an orally active progestin. This is the progestational component of the first oral contraceptive to be offered for sale (ie Enovid, 'the pill'). Treatment of the ethynyl enol ether with strong acid acid leads to yet another oral progestin employed as a contraceptive, norethindrone (6).[1]

In practice, these and all other so-called combination contraceptives are mixtures of 1-2% mestranol or ethynylestradiol and an oral progestin. It has been speculated that the discovery of the necessity of estrogen in addition to progestin for contraceptive efficacy is due to the presence of a small amount of unreduced EME (1) in early batches of 2. This when subjected to oxidation and ethynylation, would of course lead to mestranol (3). In any event, the need for the presence of estrogen in the mixture is now well established experimentally.

Norethindrone synthesis:[3][4][5] U.S. Patent 2,744,122 U.S. Patent 2,774,777

Norethindrone, 17α-Ethynyl-19-nortestosterone, is made from Estr-4-ene-3,17-dione, which in turn is synthesized by partial reduction of the aromatic region of the 3-O-methyl ether of estrone with lithium in liquid ammonia, and simultaneously of the keto group at C17 to a hydroxy group, which is then oxidized back to a keto group by chromium trioxide in acetic acid. The congugated C4-C5 olefin and the carbonyl group at C3 is then transformed to dienol ethyl ether using ethyl orthoformate. The obtained product is ethynylated by acetylene in the presence of potassium tert-butoxide. After HCl hydrolysis of the formed O-potassium derivative, during which the enol ether is also hydrolyzed, and the remaining double bond is shifted, the desired norethindrone is obtained.


Ethynerone synthesis:[6] J. Fried and T. S. Bry U.S. Patent 3,096,353 (1963, Merck & Co. Inc).

See also


  1. ^ a b c Djerassi, C.; Miramontes, L.; Rosenkranz, G.; Sondheimer, F. (1954). "Steroids. LIV.1Synthesis of 19-Nov-17α-ethynyltestosterone and 19-Nor-17α-methyltestosterone2". Journal of the American Chemical Society 76 (16): 4092.  
  2. ^ a b Frank B. Colton, U.S. Patent 2,655,518 (1952 to Searle & Co).
  3. ^ Ringold, H. J.; Rosenkranz, G.; Sondheimer, F. (1956). "Steroids. LXXX.11-Methyl-19-nortestosterone and 1-Methyl-17α-ethinyl-19-nortestosterone". Journal of the American Chemical Society 78 (11): 2477.  
  4. ^ Ueberwasser, H.; Heusler, K.; Kalvoda, J.; Meystre, C.; Wieland, P.; Anner, G.; Wettstein, A. (1963). "19-Norsteroide II. Ein einfaches Herstellungsverfahren f�r 19-Norandrostan-Derivate. �ber Steroide, 193. Mitteilung". Helvetica Chimica Acta 46: 344.  
  5. ^ Onken, D; Heublein, D (1970). "Ethinylated steroids". Die Pharmazie 25 (1): 3–9.  
  6. ^ p165 Lednicer Mitscher book 1 and p146 (2)

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.